Taniawati Supali Selected Research

Albendazole (Albenza)

3/2022	Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
1/2021	A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
1/2021	An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
11/2020	Effect of anthelmintic treatment on serum free IGF-1 and IGFBP-3: a cluster-randomized-controlled trial in Indonesia.
1/2018	Prevalence of Atopy following Mass Drug Administration with Albendazole: A Study in School Children on Flores Island, Indonesia.
3/2016	Community Rates of IgG4 Antibodies to Ascaris Haemoglobin Reflect Changes in Community Egg Loads Following Mass Drug Administration.
1/2013	Impact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia.
1/2013	The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial.
5/2008	Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
7/2005	Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taniawati Supali Research Topics

Disease

23	Infections 01/2021 - 11/2003
20	Filarial Elephantiasis (Lymphatic Filariasis) 03/2022 - 10/2002
5	Filariasis 03/2022 - 11/2003
5	Malaria 01/2017 - 03/2010
3	Insulin Resistance 01/2017 - 01/2015
2	Coinfection 01/2013 - 10/2011
2	Fever (Fevers) 05/2008 - 10/2002
1	Anemia 01/2021
1	Obesity 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Intestinal Volvulus (Volvulus) 01/2018
1	Eosinophilia 01/2018
1	Iron Deficiencies 01/2017
1	Persistent Infection 07/2015
1	Asymptomatic Infections 05/2013
1	Parasitemia 01/2013
1	Hypersensitivity (Allergy) 01/2013
1	Hypertension (High Blood Pressure) 11/2011
1	Atopic Dermatitis (Atopic Eczema) 04/2011
1	Asthma (Bronchial Asthma) 04/2011
1	Cicatrix (Scar) 11/2010
1	Tuberculosis (Tuberculoses) 11/2010
1	Protozoan Infections 11/2009
1	Parasitic Diseases (Parasitic Disease) 11/2009
1	Body Weight (Weight, Body) 10/2002

Drug/Important Bio-Agent (IBA)

12	Albendazole (Albenza)FDA Link 03/2022 - 10/2002
7	Diethylcarbamazine (Hetrazan)FDA Link 03/2022 - 10/2002
7	AntigensIBA 03/2022 - 03/2010
5	Immunoglobulin E (IgE)IBA 01/2018 - 11/2003
5	AllergensIBA 01/2013 - 04/2005
4	Immunoglobulin G (IgG)IBA 03/2022 - 11/2003
3	AntibodiesIBA 03/2022 - 11/2003
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2002
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 11/2009
3	CytokinesIBA 01/2019 - 11/2009
3	AnthelminticsIBA 01/2017 - 04/2011
2	Ivermectin (Mectizan)FDA Link 03/2022 - 01/2021
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017 - 05/2013
2	VaccinesIBA 10/2011 - 02/2010
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	AdiponectinIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	LeptinIBA 01/2021
1	SugarsIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 3IBA 11/2020
1	Carrier Proteins (Binding Protein)IBA 11/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	LeukotrienesIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Arachidonic Acid (Vitamin F)IBA 01/2018
1	Iron CompoundsIBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	IronIBA 01/2017
1	SaltsIBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 03/2015
1	LipidsIBA 03/2015
1	Glucose (Dextrose)FDA LinkGeneric 03/2015
1	Insulin (Novolin)FDA Link 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 05/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2013
1	Antimalarials (Antimalarial Agents)IBA 05/2013
1	Interleukin-5 (Interleukin 5)IBA 01/2013
1	LDL CholesterolIBA 01/2013
1	CholesterolIBA 01/2013
1	Antihypertensive Agents (Antihypertensives)IBA 11/2011
1	Tuberculin (PPD)IBA 11/2010
1	BCG Vaccine FDA Link 11/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009
1	Doxycycline (Periostat)FDA LinkGeneric 05/2008
1	ImmunosorbentsIBA 11/2003
1	EnzymesIBA 11/2003

Therapy/Procedure

13	Mass Drug Administration 03/2022 - 07/2005
1	Caloric Restriction 03/2015
1	Therapeutics 11/2011